PT1140031E - Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa - Google Patents

Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa

Info

Publication number
PT1140031E
PT1140031E PT99967009T PT99967009T PT1140031E PT 1140031 E PT1140031 E PT 1140031E PT 99967009 T PT99967009 T PT 99967009T PT 99967009 T PT99967009 T PT 99967009T PT 1140031 E PT1140031 E PT 1140031E
Authority
PT
Portugal
Prior art keywords
active substance
pharmaceutical preparation
tilidine mesylate
controlled liberation
mesylate
Prior art date
Application number
PT99967009T
Other languages
English (en)
Inventor
Thomas Strungmann
Richard Hirsch
Martin Wesseling
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of PT1140031E publication Critical patent/PT1140031E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99967009T 1998-12-23 1999-12-23 Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa PT1140031E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19859636A DE19859636A1 (de) 1998-12-23 1998-12-23 Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff

Publications (1)

Publication Number Publication Date
PT1140031E true PT1140031E (pt) 2004-03-31

Family

ID=7892368

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99967009T PT1140031E (pt) 1998-12-23 1999-12-23 Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa

Country Status (22)

Country Link
US (1) US6579536B1 (pt)
EP (1) EP1140031B1 (pt)
JP (1) JP2002533381A (pt)
AT (1) ATE252377T1 (pt)
AU (1) AU770293B2 (pt)
BR (1) BR9916575A (pt)
CA (1) CA2355891A1 (pt)
CZ (1) CZ301628B6 (pt)
DE (2) DE19859636A1 (pt)
DK (1) DK1140031T3 (pt)
ES (1) ES2207334T3 (pt)
HK (1) HK1039273A1 (pt)
HU (1) HUP0104647A3 (pt)
MX (1) MXPA01006493A (pt)
NO (1) NO320022B1 (pt)
NZ (1) NZ512079A (pt)
PL (1) PL199024B1 (pt)
PT (1) PT1140031E (pt)
SK (1) SK284901B6 (pt)
TR (1) TR200101864T2 (pt)
WO (1) WO2000038656A1 (pt)
ZA (1) ZA200105040B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1041987E (pt) 1997-12-22 2006-07-31 Euro Celtique Sa Forma farmaceutica de dosagem oral, compreendendo uma combinacao de um agonista de opioide e naltrexona
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
IL151058A0 (en) * 2000-02-08 2003-04-10 Euro Celtique Sa Controlled-release compositions containing opioid agonist and antagonist
EP2092936B1 (en) * 2000-02-08 2013-03-20 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
ES2733051T1 (es) 2002-04-05 2019-11-27 Euro Celtique Sa Matriz para liberación sostenida, invariable e independiente de compuestos activos
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
DE10233108A1 (de) * 2002-07-20 2004-01-29 Krewel Meuselbach Gmbh Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
EP1479381A1 (en) * 2003-05-19 2004-11-24 Euro-Celtique S.A. Pharmaceutical dosage form comprising a solid solution
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
CN1988889A (zh) * 2004-07-22 2007-06-27 株式会社太平洋 含托吡酯的缓释制剂及其制备方法
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
EP2168945A1 (en) * 2008-09-26 2010-03-31 Hexal Ag Crystalline forms of Tilidine Mesylate
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
MY152279A (en) 2009-03-10 2014-09-15 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
MY183489A (en) 2013-07-23 2021-02-22 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
EP3193845A1 (en) 2014-09-19 2017-07-26 The Procter and Gamble Company Pulsed release phenylephrine dosage forms
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71847A1 (pt) * 1975-02-14 1977-01-05
SK281041B6 (sk) * 1992-10-26 2000-11-07 G�decke Aktiengesellschaft Tilidíndihydrogenortofosfát, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
DK1073625T3 (da) * 1998-04-28 2003-09-29 Hexal Ag Tilidinmesylat, fremgangsmåder til dets fremstilling og et farmaceutisk præparat deraf

Also Published As

Publication number Publication date
ES2207334T3 (es) 2004-05-16
BR9916575A (pt) 2001-09-18
NO20013060L (no) 2001-06-20
JP2002533381A (ja) 2002-10-08
DE59907481D1 (de) 2003-11-27
NO320022B1 (no) 2005-10-10
ATE252377T1 (de) 2003-11-15
NO20013060D0 (no) 2001-06-20
NZ512079A (en) 2003-08-29
CZ20012167A3 (cs) 2001-11-14
CA2355891A1 (en) 2000-07-06
US6579536B1 (en) 2003-06-17
SK8922001A3 (en) 2001-12-03
HUP0104647A3 (en) 2003-12-29
CZ301628B6 (cs) 2010-05-05
EP1140031A1 (de) 2001-10-10
PL348419A1 (en) 2002-05-20
MXPA01006493A (es) 2002-06-04
HUP0104647A2 (hu) 2002-03-28
EP1140031B1 (de) 2003-10-22
AU770293B2 (en) 2004-02-19
WO2000038656A1 (de) 2000-07-06
TR200101864T2 (tr) 2002-01-21
DK1140031T3 (da) 2003-12-01
AU2286200A (en) 2000-07-31
DE19859636A1 (de) 2000-06-29
SK284901B6 (sk) 2006-02-02
ZA200105040B (en) 2002-05-22
HK1039273A1 (en) 2002-04-19
PL199024B1 (pl) 2008-08-29

Similar Documents

Publication Publication Date Title
PT1140031E (pt) Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
IS5404A (is) Lyfjablanda sem inniheldur klódrónat sem virkt innihaldsefni og síliseraðan örkristallaðan sellulósa sem burðarefni
MXPA03007712A (es) Sales farmaceuticas.
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
TR200100172T2 (tr) Oral katı doz formunda eprosartan içeren biyolojik bakımdan kuvvetlendirilmiş formülasyonlar
BR9810495A (pt) Composição farmacêutica
UA70921C2 (uk) Похідні 2-(імінометил)амінофенілу, спосіб їх одержання (варіанти) та фармацевтична композиція, що містить ці сполуки
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
HN1998000144A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa.
WO2001000617A3 (en) Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
HUP0004900A2 (hu) Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
ES2161913T3 (es) Complejos cationicos trinucleares de platino que tienen una actividad antitumoral y composiciones farmaceuticas que los contienen.
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
SE9803107D0 (sv) Novel Compunds
CA2409845A1 (en) Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
NO20014889D0 (no) Fremgangsmåte for fremstilling av medisinske midler
SE9803277D0 (sv) Novel compounds